Broadwood Partners, L.P. - Director, 10%+ Owner at Lineage Cell Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type: Company
Role: Director, 10%+ Owner
Stock Symbol: LCTX on NYSE
Industry: Biological Products, (No Diagnostic Substances)
All Insider Reports: All Insider Reports

Broadwood Partners, L.P. - trading volume in the past year for Lineage Cell Therapeutics, Inc.

	Shares	%	Avg Price	Total $
Buys	+7.89M	100%	$0.76	+$6M
Sells
Net	+7.89M	100%		+$6M

Holdings reported by Broadwood Partners, L.P. for Lineage Cell Therapeutics, Inc.

Security	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Shares	49.6M	$37.7M	$0.76	Jan 27, 2025	Direct
Common Shares	49.6M	$37.7M	$0.76	Jan 27, 2025	Indirect
Common Warrant	7.89M			Jan 27, 2025	Direct	Common Shares
Common Warrant	7.89M			Jan 27, 2025	Indirect	Common Shares

Transactions reported by Broadwood Partners, L.P. for Lineage Cell Therapeutics, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.